Elcelyx Therapeutics Company

Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.

Technology: Small Molecules
Headquarters: San Diego, California, United States
Total Funding: $96.8M
Last Funding Type: Series E
Founded Date: 2010
Investors Number: 6
Industry: PharmTech
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investor Type: For Profit
Funding Status: Late Stage Venture